Erik Hameister
Overview
Explore the profile of Erik Hameister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landspersky T, Stein M, Sacma M, Geuder J, Braitsch K, Riviere J, et al.
Blood Adv
. 2024 Aug;
8(20):5400-5414.
PMID: 39159429
Osteopenia and osteoporosis are common long-term complications of the cytotoxic conditioning regimen for hematopoietic stem cell transplantation (HSCT). We examined mesenchymal stem and progenitor cells (MSPCs), which include skeletal progenitors,...
2.
Wartewig T, Daniels J, Schulz M, Hameister E, Joshi A, Park J, et al.
Nat Cancer
. 2023 Sep;
4(10):1508-1525.
PMID: 37723306
The PDCD1-encoded immune checkpoint receptor PD-1 is a key tumor suppressor in T cells that is recurrently inactivated in T cell non-Hodgkin lymphomas (T-NHLs). The highest frequencies of PDCD1 deletions...
3.
Wagner A, Wostrack M, Hartz F, Heim J, Hameister E, Hildebrandt M, et al.
Brain Spine
. 2023 Jun;
3:101756.
PMID: 37383462
Introduction: Postoperative hemorrhage after adult cranial neurosurgery is a serious complication with substantial morbidity and mortality. Research Question: We investigated if an extended preoperative screening and an early treatment of...
4.
Hecker J, Wahida A, Hameister E, Filo A, Ruland J, Bassermann F, et al.
EJHaem
. 2022 Jul;
2(2):280-284.
PMID: 35845280
Allogeneic hematopoietic stem cell transplantations (HSCTs) represent a curative strategy for treating hematologic malignancies yet bear dangerous and frequently life-threatening complications including the development of graft-versus-host disease. Here, we present...
5.
Kurgyis Z, Vornholz L, Pechloff K, Kemeny L, Wartewig T, Muschaweckh A, et al.
Sci Immunol
. 2021 Nov;
6(65):eabi4425.
PMID: 34826258
Psoriasis is a chronic inflammatory skin disease arising from poorly defined pathological cross-talk between keratinocytes and the immune system. BCL10 (B cell lymphoma/leukemia 10) and MALT1 (mucosa-associated lymphoid tissue lymphoma...
6.
Landspersky T, Sacma M, Riviere J, Hecker J, Hettler F, Hameister E, et al.
Blood
. 2021 Oct;
139(5):690-703.
PMID: 34657154
The cellular mechanisms required to ensure homeostasis of the hematopoietic niche and the ability of this niche to support hematopoiesis upon stress remain elusive. We here identify Wnt5a in Osterix+...
7.
Sipol A, Hameister E, Xue B, Hofstetter J, Barenboim M, Ollinger R, et al.
Blood
. 2021 Apr;
139(8):1184-1197.
PMID: 33908607
Cancer cells are in most instances characterized by rapid proliferation and uncontrolled cell division. Hence, they must adapt to proliferation-induced metabolic stress through intrinsic or acquired antimetabolic stress responses to...
8.
Hameister E, Stolz S, Fuhrer Y, Thienemann F, Schaer D, Nemeth J, et al.
Hemasphere
. 2020 Sep;
4(4):e453.
PMID: 32885145
No abstract available.
9.
Wartewig T, Kurgyis Z, Keppler S, Pechloff K, Hameister E, Ollinger R, et al.
Nature
. 2017 Nov;
553(7687):238.
PMID: 29186126
This corrects the article DOI: 10.1038/nature24649.
10.
Wartewig T, Kurgyis Z, Keppler S, Pechloff K, Hameister E, Ollinger R, et al.
Nature
. 2017 Nov;
552(7683):121-125.
PMID: 29143824
T cell non-Hodgkin lymphomas are a heterogeneous group of highly aggressive malignancies with poor clinical outcomes. T cell lymphomas originate from peripheral T cells and are frequently characterized by genetic...